We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is taking a more active role in the growing debate over the independence of its advisory committee members in an effort to head off potential legislative action.
The FCC is considering whether to expand available radio frequency (RF) for implanted and body-worn wireless devices, but manufacturers disagree on whether additional RF is needed.
Device and diagnostics makers can avoid being blamed for inflated healthcare costs by focusing on competitive strategies that add value to their products, experts say.
Based on encouraging clinical trial data, GlaxoSmithKline (GSK) will likely file for regulatory approval to market its pandemic bird flu vaccine within the next few months.
The Journal of the American Medical Association (JAMA) has published another correction in which they said the authors of an article did not disclose ties to the drug industry when they submitted their article manuscript.
The Department of Justice’s (DOJ) Antitrust Division has launched a criminal investigation into a proposed patent settlement between Bristol-Myers Squibb (BMS), sanofi-aventis and Apotex regarding the blood thinner Plavix, BMS announced July 27.
The federal government and industry must overhaul the way medications are named, labeled and packaged in order to curb an ever-growing number of medical errors involving the administration and prescription of drugs, a recent federal study concluded.
Lawmakers are continuing their assault on brand companies’ efforts to squeeze out generic competition by introducing legislation to ban another one of their tactics.
A more efficient and accurate method of assessing biological reactions to chemical compounds will accelerate new drug development, according to a paper published online July 24 by the journal Proceedings of the National Academy of Sciences.